TRDA FY 2023 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TRDAEntrada Therapeutics, Inc.

$502M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$129M

Gross Profit

$129M100.0% margin

Operating Income

-$3M-2.5% margin

Net Income

-$7M-5.2% margin

EPS (Diluted)

$-0.20

Cash Flow

Operating Cash Flow

$140M

Free Cash Flow

$134M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$469M

Total Liabilities

$227M

Stockholders' Equity

$242M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$129M	$0	—
Gross Profit	$129M	$0	—
Operating Income	-$3M	-$97M	+96.7%
Net Income	-$7M	-$95M	+92.9%